Browse Category

Health Insurance News 27 January 2026 - 29 January 2026

UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth Group shares fell 1.2% to $290.50 Thursday after regulators proposed a 0.09% Medicare Advantage rate hike for 2027, far below expectations. The company warned of possible benefit cuts and a $1.6 billion charge tied to a cyberattack. UnitedHealth stock plunged 19% Tuesday after executives called the proposal “disappointing.” CMS will issue final rates by April 6.
UnitedHealth stock rebounds after rout; Medicare Advantage rates set the next test

UnitedHealth stock rebounds after rout; Medicare Advantage rates set the next test

UnitedHealth shares rose 4% to $294.02 Wednesday, rebounding after a 19% plunge Tuesday triggered by a weak 2026 outlook and a Medicare Advantage payment proposal. The company reported fourth-quarter net earnings of $0.01 per share, including a $1.6 billion cyberattack charge. Investors await Washington’s final 2027 Medicare rate decision, due by April 6.
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth shares rose about 3% Wednesday after plunging nearly 20% Tuesday on a weak 2026 revenue forecast and a minimal 2027 Medicare Advantage payment update. The U.S. proposed a 0.09% hike in 2027 payments, far below market expectations. Investors await the final Medicare Advantage rate announcement in early April. Peers like Elevance Health also warned of ongoing cost pressures.
UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth shares rose 1.2% to $286.15 early Wednesday after plunging nearly 20% Tuesday, following a draft Medicare Advantage rate update and a weak 2026 outlook. The draft proposed a 0.09% average payment increase for 2027, far below expectations, triggering an $80 billion selloff in managed care stocks. UnitedHealth expects 2026 revenue to fall to just under $439 billion, with Medicare Advantage membership dropping by up to 1.4 million.
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
Elevance Health stock sinks 14% as Medicare Advantage rate shock hits insurers ahead of earnings

Elevance Health stock sinks 14% as Medicare Advantage rate shock hits insurers ahead of earnings

Elevance Health shares fell 14.3% to $322.92 in after-hours trading Tuesday after CMS announced a nearly flat 2027 Medicare Advantage payment update. The move triggered a sector-wide selloff, with managed-care stocks losing about $80 billion in market value. Investors now await Elevance’s quarterly results due Wednesday morning for further guidance.
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana shares fell about 12% in premarket trading Tuesday after a U.S. proposal signaled minimal Medicare Advantage payment growth for 2027. The Centers for Medicare & Medicaid Services set a net average increase of 0.09%, citing risk score changes and new limits on chart review diagnoses. UnitedHealth and CVS Health also dropped around 9%. Investors await the April 6 final rate notice.
CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS Health shares fell about 9% in premarket trading after CMS announced a 0.09% net average payment increase for 2027 Medicare Advantage plans, far below investor expectations. The agency set a Feb. 25 deadline for comments and will finalize rates by April 6. UnitedHealth and Humana also dropped in after-hours trading. Insurers face pressure as Medicare Advantage remains a key profit source.
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth shares fell over 10% in after-hours trading Monday after U.S. officials proposed a 0.09% average payment increase for Medicare Advantage plans in 2027. The Centers for Medicare & Medicaid Services also outlined changes to risk adjustment, including limits on payments tied to certain chart reviews. CVS Health and Humana shares dropped as much as 15%. UnitedHealth reports earnings and 2026 guidance Tuesday morning.
1 2 3 4 7

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop